Tucatinib125mg

27/11/2025

Tucatinib is an oral targeted therapy used to treat HER2-positive metastatic breast cancer, including cases where the cancer has spread to the brain.
It works by blocking the HER2 signaling pathway, helping slow down the growth of cancer cells.

Tucatinib is usually taken together with trastuzumab and capecitabine, especially for patients who have already tried other HER2 treatments.
This combination can improve treatment response and delay cancer progression.

This medicine must be used under the supervision of an oncologist.

27/11/2025

Tucatinib – Targeted Therapy for HER2-Positive Breast Cancer

Tucatinib is an advanced targeted therapy used in combination with other medicines to treat HER2-positive metastatic breast cancer, including cases that have spread to the brain (brain metastases).
It works by selectively blocking the HER2 signaling pathway, helping slow down cancer growth while keeping side-effects more manageable than many traditional treatments.

Key Points:
• Designed for HER2-positive breast cancer
• Often used with trastuzumab and capecitabine
• Can be effective even when previous HER2 treatments stop working
• Oral tablet — convenient for patients
• Helps improve progression-free survival and overall response.

02/11/2025

Tucatinib is a prescription medication primarily used in certain types of breast cancer. Here’s a clear breakdown:

1. Drug Class
• Type: Tyrosine kinase inhibitor (TKI)
• Target: HER2 (human epidermal growth factor receptor 2)
• Mechanism: Blocks the HER2 protein, which promotes growth of cancer cells.

2. Indications
• Used for HER2-positive breast cancer, especially:
• Metastatic (spread to other parts of the body)
• Often combined with other medications like trastuzumab and capecitabine
• Especially for patients with brain metastases from HER2-positive breast cancer, as it crosses the blood-brain barrier better than some other drugs.

3. How It’s Taken
• Oral tablet
• Usually taken twice daily, often with food
• Dose adjustment may be needed for liver problems.

4. Common Side Effects
• Diarrhea
• Hand-foot syndrome (redness, pain, or swelling on palms/soles)
• Fatigue
• Nausea or vomiting
• Liver enzyme elevation (requires monitoring)

5. Important Notes
• Should be used under strict medical supervision.
• Regular liver function tests are recommended.
• Often part of a combination therapy, not used alone.

19/10/2025

A next-generation EGFR inhibitor used for advanced non-small cell lung cancer (NSCLC) — including T790M-positive mutations.

18/10/2025

Breast cancer therapy. Used in the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer, often in combination with:
• Fulvestrant or aromatase inhibitors (like letrozole, anastrozole, or exemestane), or
• As monotherapy (alone) if other endocrine therapies have failed.

⸻

💉 Dosage (typical adult):
• 150 mg twice daily (with fulvestrant or aromatase inhibitor)
• 200 mg twice daily (monotherapy)
• Taken with or without food
• Continue as long as patient benefits and no unacceptable toxicity occurs.

18/10/2025

💊 Abemaciclib (Verzenio) — advanced targeted therapy for HR-positive, HER2-negative breast cancer.
Helps stop cancer cell growth and improves survival outcomes.

🌿 Trusted oncology solution.



⸻

🧬 Detailed Version (for post or product description):

Abemaciclib (Verzenio) is an advanced CDK4/6 inhibitor used for hormone receptor-positive (HR+), HER2-negative breast cancer.
It targets cancer cells directly, slowing their growth and helping patients live longer with better quality of life.

✅ Used alone or with hormone therapy
✅ Improves survival in advanced breast cancer
✅ Global standard in targeted oncology treatme

16/02/2024

04/01/2024

Generic version of ozemoic , mounjaro, molnupiravir , paxlovid, anticancer medicine at cheap price , please contact with me on whatsapp +8801929123476
, only generic version exporter .

03/01/2024

Paxlovid

25/12/2023

10/12/2023

Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor. +8801929123476 WhatsApp